Willing to see this through and how market reacts to quarterly and improved revenue and how new sales force pans out. Also, if (big if) vaccine division is divested I'd expect improved sentiment and small re-rate on this stock. Oddly, the best effect the Vax division could have this point is getting rid of it.
Willing to see this through and how market reacts to quarterly...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 475 | $18.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.91 | 100 | 1 |
View Market Depth
| Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |